Chemogenetic management of neuropathic pain
Author:
Open Access
- 27 September 2017
- journal article
- editorial
- Published by Oxford University Press (OUP) in Brain
- Vol. 140 (10) , 2522-2525
Abstract
This scientific commentary refers to ‘Using an engineered glutamate-gated chloride channel to silence sensory neurons and treat neuropathic pain at the source’, by Weir et al. (doi:10.1093/brain/awx201).Keywords
This publication has 10 references indexed in Scilit:
- Using an engineered glutamate-gated chloride channel to silence sensory neurons and treat neuropathic pain at the sourceBrain, 2017
- Neuropathic painNature Reviews Disease Primers, 2017
- Inhibition of mechanical allodynia in neuropathic pain by TLR5-mediated A-fiber blockadeNature Medicine, 2015
- Peripheral nervous system origin of phantom limb painPain, 2014
- Primary afferent input critical for maintaining spontaneous pain in peripheral neuropathyPain, 2014
- TRP Channels and PainAnnual Review of Cell and Developmental Biology, 2013
- An Engineered Glutamate-gated Chloride (GluCl) Channel for Sensitive, Consistent Neuronal Silencing by IvermectinJournal of Biological Chemistry, 2013
- Scraping through the ice: uncovering the role of TRPM8 in cold transductionAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2011
- Differential maturation of chloride homeostasis in primary afferent neurons of the somatosensory systemInternational Journal of Developmental Neuroscience, 2007
- Reversible Silencing of Neuronal Excitability in Behaving Mice by a Genetically Targeted, Ivermectin-Gated Cl− ChannelNeuron, 2007